SERA — SERA PROGNOSTICS, INC.

Nasdaq · Health Care · Health Care Providers & Services · CIK 1534969 ·
Last close
$2.15
Market Cap
$82.11M
52W High
$2.54
52W Low
$1.56
ADV30
58,269
Next earnings
2026-08-05
Sera Prognostics, Inc., a women's health company, discovers, develops, and commercializes blood-based biomarker tests, and predictive analytic products and services in the United States. The company develops the PreTRM test, a non-invasive blood test given to a pregnant woman, carrying a single fetus, during weeks 18 through 20 of gestation. It is also involved in the development of a pipeline of novel blood-based biomarker tests and predictive analytic products and services for pregnancy related conditions, such as time-to-birth, predictive analytics product, pregnancy risk prediction panel, preeclampsia, and fetal growth restriction. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 14,000 -28,000 -9,360,000 -8,399,000 93,544,000 4,175,000 25,924,000
Dec 2025 10,000 -32,000 -8,954,000 -7,881,000 101,933,000 3,944,000 26,525,000
Sep 2025 16,000 -25,000 -8,980,000 -7,814,000 108,125,000 4,081,000 25,943,000
Jun 2025 17,000 -24,000 -9,320,000 -8,046,000 111,828,000 5,016,000 23,602,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-25,623,000
Investing CF
$-28,502,000
Financing CF
$54,026,000
CapEx
$-726,000
Dividends Paid
Buybacks
EPS Diluted TTM
$-0.68
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$-311,722,000
Inventory
Receivables
$12,000
ST Investments
$35,257,000
EBIT TTM
$-31,919,000
Pretax Income TTM
$-31,928,000
Interest Exp TTM
$9,000
Analysts
1

Yahoo Snapshot (yfinance, live)

Total Revenue
$57,000
EBITDA
$-35,813,000
Free Cash Flow
$-18,903,124
Enterprise Value
$36,162,560
Total Cash
$47,401,000
Total Debt
$2,505,000
Shares Out
38,190,966
Trailing EPS
$-0.67
Book Value
$1.94
ROE
-39.6%
ROA
-21.6%
Div Yield

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 81,000 -36,504,000 -31,928,000 101,933,000 26,525,000 -25,623,000
Dec 2024 77,000 -36,635,000 -32,898,000 72,575,000 24,772,000 -14,189,000
Dec 2023 306,000 -39,821,000 -36,242,000 95,441,000 25,283,000 -27,188,000
Dec 2022 268,000 -45,652,000 -44,186,000 116,329,000 17,386,000 -34,610,000

TTM Snapshot

Revenues TTM
$238,000
NetIncome TTM
$-36,185,000
OpCashFlow TTM
$0
Assets (Latest)
$95,441,000
Forward EPS
$-0.69

Peers — same industry

TickerNameMarket CapLastDaily %
PARK Park Dental Partners, Inc. $82.72M $18.32
PCSC Perceptive Capital Solutions Corp $99.45M $11.16
DCGO DocGo Inc. $62.23M $0.63
XGN EXAGEN INC. $111.62M $4.62
ALPS Alps Group Inc $121.24M $0.73

News headlines (Yahoo Finance, 1h cache)

Sera Prognostics (SERA) Loses 27% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
2026-05-14 13:35 · Yahoo
Will Sera Prognostics (NASDAQ:SERA) Spend Its Cash Wisely?
2026-05-08 10:39 · Yahoo
Sera Prognostics, Inc. Q1 2026 Earnings Call Summary
2026-05-07 12:30 · Yahoo
Sera Prognostics Q1 Earnings Call Highlights
2026-05-07 05:12 · Yahoo
Sera Prognostics, Inc. (SERA) Reports Q1 Loss, Misses Revenue Estimates
2026-05-06 22:30 · Yahoo
SERA PROGNOSTICS REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS
2026-05-06 20:05 · Yahoo
SERA PROGNOSTICS ANNOUNCES CONFERENCE CALL AND WEBCAST OF FIRST QUARTER FISCAL YEAR 2026 FINANCIAL RESULTS ON MAY 6, 2026
2026-04-22 12:05 · Yahoo
Sera Prognostics (SERA) Upgraded to Buy: What Does It Mean for the Stock?
2026-03-31 16:00 · Yahoo
5 Top-Ranked Stocks With Rising P/E That Investors Can Bet On
2026-03-31 12:30 · Yahoo
Sera Prognostics, Inc. Q4 2025 Earnings Call Summary
2026-03-19 12:30 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.